TOPIC
Risk factors and therapeutic approach of medication-related osteonecrosis of the jaw.
VISION
Prolonged survival and improved quality of life in patients receiving BMAs therapy.
MISSION
Estimating the risk and rate of MRONJ in patients receiving BMAs therapy.
PROJECT TITLE 1
Investigating the efficacy and safety of combined anti-angiogenic and anti-resorptive treatments in bone cancer patients:
Systematic Review and Meta-analysis.
PROJECT TITLE 2
Investigating the resolution of medication related osteonecrosis of the jaw: prospective observational study.